Enhancing access to breast cancer prevention trials
Official title: Enhancing access in breast cancer prevention clinical trials
Funded at University of Kansas Medical Center · NIH-11415117 · Data updated 2026-11-12
This grant aims to make breast cancer prevention trials easier to join for people from all backgrounds so the findings help everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project start | September 4, 2025 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $135,951 |
| NIH project number | 5R50CA305048-02 |
| Project ID | NIH-11415117 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults at risk for breast cancer and those interested in prevention research who face barriers to trial access.
✕Less likely to help
Individuals not seeking participation in prevention trials or living far from trial sites without feasible access may see limited direct benefit.
What this research studies
The project focuses on removing barriers that prevent people from joining breast cancer prevention trials, such as lack of awareness, transportation, and time or financial costs. By modernizing how we engage communities and deliver prevention research, it aims to broaden participation across diverse populations. As a patient or caregiver, you could benefit from earlier access to cutting-edge prevention strategies and more representative results that apply to you. The team collaborates locally and nationally to streamline recruitment and improve care delivery in breast cancer prevention. The work is centered on making prevention research more accessible and meaningful for those at risk.
Why it matters
Potential benefit: If successful, it could expand who can participate in prevention trials and ensure findings apply to a broader population.
How similar studies have gone: There is growing evidence that optimized engagement can increase diverse participation in cancer prevention trials, but more work is needed to generalize.
Where this research is happening
-
University of Kansas Medical Center
Kansas City, United States Active
Researchers
- Principal investigator: Nye, Lauren Elizabeth — University of Kansas Medical Center
- Study coordinator: Nye, Lauren Elizabeth
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
-
Translational breast cancer research to improve treatment options
A comprehensive program at Baylor College of Medicine is focusing on breast cancer; researchers will advance targeted therapies and biomarkers to help patients with aggressive or hard-to-treat forms.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Co-Targeting IL-6 and CDK4/6 to Prevent TNBC in Women Veterans
A study aims to block two cancer-promoting pathways (IL-6 and CDK4/6) to prevent or reduce progression of triple-negative breast cancer in women veterans.
-
Gut bacteria and metabolites linked to breast density and cancer risk
A small, patient-friendly study will explore whether gut bacteria and their byproducts are connected to high breast density, which can raise cancer risk and make screening less accurate.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.